Hungarian National Systemic Amyloidosis Registry
Recruiting
Observational Study
Systemic Amyloidosis
ATTR Amyloidosis
AL Amyloidosis
Amyloid Cardiomyopathy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Semmelweis University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This registry is an observational, multicenter, retrospective and prospective, non-pharmacological study designed to collect and analyze data from patients with systemic amyloidosis treated in inpatient and outpatient cardiology, hematology, nephrology, and neurology departments across Hungary. The registry was established in 2025.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of systemic amyloidosis
* Patients aged ≥18 years at the time of enrollment
* Signed informed consent form by the patient
* Treating physician's consent
* Availability of accessible medical history
Exclusion Criteria:
* Lack of informed consent in the prospective s…
Contacts